• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移民对欧洲罕见病医疗服务的影响:以血红蛋白病为例。

The impact of migrations on the health services for rare diseases in Europe: the example of haemoglobin disorders.

作者信息

Angastiniotis Michalis, Vives Corrons Joan-Lluis, Soteriades Elpidoforos S, Eleftheriou Androulla

机构信息

Thalassaemia International Federation (TIF), 31 Ifigeneias Street, 2007 Strovolos, Nicosia, Cyprus.

出版信息

ScientificWorldJournal. 2013;2013:727905. doi: 10.1155/2013/727905. Epub 2013 Mar 18.

DOI:10.1155/2013/727905
PMID:23576907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3614063/
Abstract

Migration from different parts of the world to several European countries leads to the introduction of haemoglobinopathy genes into the population, which creates several demanding needs for prevention and treatment services for Hb disorders. In this paper we examined the degree to which European health services have responded to such challenges and in particular to health services necessary to address the needs of patients with thalassaemia and sickle cell disease (SCD). Information on available services was obtained from international organizations, collaborated European project, and the Thalassaemia International Federation (TIF) Databases, which include information from published surveys, registries, field trips, and delegation visits to countries and regions by expert advisors, local associations, and other collaborators' reports. Results show that countries with traditional strong prevention and treatment programs are well prepared to face the above challenges, while others are urgently needed to address these problems in a systematic way. The Thalassaemia International Federation (TIF) is committed to monitor the progress, raise awareness, and support the promotion of more immigrant-oriented health policies to ensure their integration in society and their access to appropriate, adequate, and timely health services.

摘要

来自世界不同地区的人口向几个欧洲国家迁移,导致血红蛋白病基因引入当地人群,这对血红蛋白疾病的预防和治疗服务提出了诸多迫切需求。在本文中,我们考察了欧洲卫生服务应对此类挑战的程度,特别是满足地中海贫血和镰状细胞病(SCD)患者需求所需的卫生服务。关于现有服务的信息来自国际组织、合作的欧洲项目以及地中海贫血国际联合会(TIF)数据库,这些信息包括已发表的调查、登记册、实地考察以及专家顾问、当地协会和其他合作者对各国和各地区的访问报告。结果表明,拥有传统强大预防和治疗项目的国家已做好充分准备应对上述挑战,而其他国家则迫切需要系统地解决这些问题。地中海贫血国际联合会(TIF)致力于监测进展情况、提高认识,并支持推广更多以移民为导向的卫生政策,以确保他们融入社会并获得适当、充足和及时的卫生服务。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dde/3614063/6c02319fe8e4/TSWJ2013-727905.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dde/3614063/523fc67fa9c9/TSWJ2013-727905.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dde/3614063/4128ede344b1/TSWJ2013-727905.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dde/3614063/6c02319fe8e4/TSWJ2013-727905.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dde/3614063/523fc67fa9c9/TSWJ2013-727905.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dde/3614063/4128ede344b1/TSWJ2013-727905.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dde/3614063/6c02319fe8e4/TSWJ2013-727905.003.jpg

相似文献

1
The impact of migrations on the health services for rare diseases in Europe: the example of haemoglobin disorders.移民对欧洲罕见病医疗服务的影响:以血红蛋白病为例。
ScientificWorldJournal. 2013;2013:727905. doi: 10.1155/2013/727905. Epub 2013 Mar 18.
2
Haemoglobinopathies in Europe: health & migration policy perspectives.欧洲的血红蛋白病:健康与移民政策视角
Orphanet J Rare Dis. 2014 Jul 1;9:97. doi: 10.1186/1750-1172-9-97.
3
Genetic Blood Disorders Survey in the Sultanate of Oman.阿曼苏丹国的遗传性血液疾病调查。
J Trop Pediatr. 2003 Jul;49 Suppl 1:i1-20.
4
Epidemiology of rare anaemias in Europe.欧洲罕见贫血症的流行病学。
Adv Exp Med Biol. 2010;686:375-96. doi: 10.1007/978-90-481-9485-8_22.
5
Utilization of health care services by migrants in Europe-a systematic literature review.欧洲移民对医疗保健服务的利用——一项系统的文献综述
Br Med Bull. 2017 Jan 1;121(1):5-18. doi: 10.1093/bmb/ldw057.
6
Interventions to Improve Vaccination Uptake and Cost Effectiveness of Vaccination Strategies in Newly Arrived Migrants in the EU/EEA: A Systematic Review.干预措施以提高欧盟/欧洲经济区新抵达移民的疫苗接种率和疫苗接种策略的成本效益:系统评价。
Int J Environ Res Public Health. 2018 Sep 20;15(10):2065. doi: 10.3390/ijerph15102065.
7
Haemoglobinopathies and other rare anemias in Spain: ten years of a nationwide registry (REHem-AR).西班牙的血红蛋白病和其他罕见性贫血症:全国登记研究(REHem-AR)十年
Ann Hematol. 2024 Aug;103(8):2743-2755. doi: 10.1007/s00277-024-05788-8. Epub 2024 May 20.
8
Frequency of haemoglobinopathies at premarital health screening in Dohuk, Iraq: implications for a regional prevention programme.伊拉克杜胡克婚前健康检查中血红蛋白病的频率:对区域预防计划的影响。
East Mediterr Health J. 2010 Apr;16(4):381-5.
9
Depression and anxiety among migrants in Austria: a population based study of prevalence and utilization of health care services.奥地利移民中的抑郁和焦虑:一项基于人群的患病率和卫生保健服务利用研究。
J Affect Disord. 2013 Oct;151(1):220-8. doi: 10.1016/j.jad.2013.05.081. Epub 2013 Jun 27.
10
The role of the Thalassaemia International Federation in health professionals' education.地中海贫血国际联合会在卫生专业人员教育中的作用。
Pediatr Endocrinol Rev. 2004 Dec;2 Suppl 2:242-4.

引用本文的文献

1
Long-term efficacy and safety of mitapivat in non-transfusion-dependent α- or β-thalassaemia: An open-label phase 2 study.米塔匹伐在非输血依赖型α或β地中海贫血中的长期疗效和安全性:一项开放标签的2期研究。
Br J Haematol. 2025 Jun;206(6):1764-1773. doi: 10.1111/bjh.20058. Epub 2025 May 20.
2
Alpha+ Thalassemia in Northwestern Tanzania: Molecular and Hematological Insights From Newborn Screening.坦桑尼亚西北部的α+地中海贫血:新生儿筛查的分子和血液学见解
J Blood Med. 2025 May 15;16:241-250. doi: 10.2147/JBM.S514273. eCollection 2025.
3
Establishment of an α-thalassemia mouse model through fetal liver cell transplantation and analysis of hematological parameters.

本文引用的文献

1
Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates.全球新生儿镰状细胞血红蛋白病流行病学:基于当代地统计学模型的地图和人群估计。
Lancet. 2013 Jan 12;381(9861):142-51. doi: 10.1016/S0140-6736(12)61229-X. Epub 2012 Oct 25.
2
A national registry of haemoglobinopathies in Greece: deducted demographics, trends in mortality and affected births.希腊血红蛋白病国家登记处:推断的人口统计学资料、死亡率趋势和受影响的出生情况。
Ann Hematol. 2012 Sep;91(9):1451-8. doi: 10.1007/s00277-012-1465-7. Epub 2012 Apr 19.
3
Interpretations of informed choice in antenatal screening: a cross-cultural, Q-methodology study.
通过胎肝细胞移植建立α地中海贫血小鼠模型并分析血液学参数。
Sci Rep. 2025 Feb 28;15(1):7183. doi: 10.1038/s41598-025-91792-5.
4
Renal Findings in Patients with Thalassemia at Abdominal Ultrasound: Should We Still Talk about "Incidentalomas"? Results of a Long-Term Follow-Up.地中海贫血患者腹部超声检查中的肾脏表现:我们是否仍应提及“偶发瘤”?一项长期随访结果
Diagnostics (Basel). 2024 Sep 15;14(18):2047. doi: 10.3390/diagnostics14182047.
5
Systematic review and evidence gap assessment of the clinical, quality of life, and economic burden of alpha-thalassemia.α地中海贫血临床、生活质量及经济负担的系统评价与证据缺口评估
EJHaem. 2024 Apr 2;5(3):541-547. doi: 10.1002/jha2.882. eCollection 2024 Jun.
6
Current Status of Molecular Diagnosis of Hereditary Hemolytic Anemia in Korea.韩国遗传性溶血性贫血的分子诊断现状。
J Korean Med Sci. 2024 May 13;39(18):e162. doi: 10.3346/jkms.2024.39.e162.
7
Oxidative Stress and Antioxidant Status in Adult Patients with Transfusion-Dependent Thalassemia: Correlation with Demographic, Laboratory, and Clinical Biomarkers.输血依赖型地中海贫血成年患者的氧化应激与抗氧化状态:与人口统计学、实验室及临床生物标志物的相关性
Antioxidants (Basel). 2024 Apr 10;13(4):446. doi: 10.3390/antiox13040446.
8
Ten years of a neonatal screening program for hemoglobinopathies in Friuli-Venezia Giulia: first regional experience in Italy.十年的新生儿血红蛋白病筛查计划在弗留利-威尼斯朱利亚地区:意大利的首次区域经验。
Blood Transfus. 2024 Nov;22(6):529-536. doi: 10.2450/BloodTransfus.646. Epub 2023 Nov 30.
9
Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia.钙通道阻滞剂预防输血依赖型β地中海贫血患者铁过载所致心肌病。
Cochrane Database Syst Rev. 2023 Nov 17;11(11):CD011626. doi: 10.1002/14651858.CD011626.pub3.
10
The pivotal role of HbA1c assay to detect hemoglobinopathies: A 5-year observational retrospective study in the population of Southern France.糖化血红蛋白(HbA1c)检测在诊断血红蛋白病中的关键作用:法国南部人群的一项5年观察性回顾研究
Health Sci Rep. 2023 Jul 16;6(7):e1270. doi: 10.1002/hsr2.1270. eCollection 2023 Jul.
产前筛查中知情选择的解读:一项跨文化的 Q 方法学研究。
Soc Sci Med. 2012 Apr;74(7):997-1004. doi: 10.1016/j.socscimed.2011.12.021. Epub 2012 Jan 25.
4
Sickle cell and thalassaemia: global public health issues come of age.镰状细胞病和地中海贫血:步入成熟阶段的全球公共卫生问题
Ethn Health. 2011 Aug-Oct;16(4-5):299-311. doi: 10.1080/13557858.2011.588397.
5
The management of iron chelation therapy: preliminary data from a national registry of thalassaemic patients.铁螯合疗法的管理:来自全国地中海贫血患者登记处的初步数据。
Anemia. 2011;2011:435683. doi: 10.1155/2011/435683. Epub 2011 Jun 5.
6
Thalassemia as a global health problem: recent progress toward its control in the developing countries.地中海贫血症作为一个全球性健康问题:发展中国家在控制该病方面的最新进展。
Ann N Y Acad Sci. 2010 Aug;1202:17-23. doi: 10.1111/j.1749-6632.2010.05546.x.
7
Complications and treatment of patients with β-thalassemia in France: results of the National Registry.法国β-地中海贫血患者的并发症和治疗:国家登记处的结果。
Haematologica. 2010 May;95(5):724-9. doi: 10.3324/haematol.2009.018051. Epub 2009 Dec 8.
8
Prevention strategies for severe hemoglobinopathies in endemic and nonendemic immigration countries: the Latium example.预防地方性和非地方性移民国家严重血红蛋白病的策略:拉齐奥地区的实例。
Prenat Diagn. 2009 Dec;29(12):1171-4. doi: 10.1002/pd.2382.
9
Raising awareness of carrier testing for hereditary haemoglobinopathies in high-risk ethnic groups in the Netherlands: a pilot study among the general public and primary care providers.提高荷兰高危少数民族中遗传性血红蛋白病携带者检测的意识:普通公众和初级保健提供者的试点研究。
BMC Public Health. 2009 Sep 15;9:338. doi: 10.1186/1471-2458-9-338.
10
The influence of treatment in specialized centers on survival of patients with thalassemia major.专业中心的治疗对重型地中海贫血患者生存率的影响。
Am J Hematol. 2009 May;84(5):317-8. doi: 10.1002/ajh.21398.